Publications by authors named "Ni M Wiliantari"
Effectiveness of the Antiparasitic Combination of Albendazole and Praziquantel As Compared With Albendazole Monotherapy in the Treatment of Neurocysticercosis in Children: A Systematic Review and Meta-Analysis.
Cureus
July 2024
Article Synopsis
- * This study investigates whether a combination therapy of albendazole and praziquantel is more effective than albendazole alone in treating pediatric neurocysticercosis, following strict review and analysis protocols.
- * Researchers conducted a systematic review that assessed various randomized controlled trials and quantitatively analyzed the results, utilizing statistical models to compare treatment effectiveness based on lesion resolution in children.
Chronic venous insufficiency is a medical condition that impacts the venous system in the lower limbs. The primary characteristic of this condition is the continual elevation of pressure within the leg veins due to walking, which leads to a range of associated issues, such as discomfort, swelling, alterations in the skin, and the development of ulcers. Sclerotherapy has emerged as a potentially effective treatment for chronic venous insufficiency, involving the injection of a sclerosing agent into the affected veins.
View Article and Find Full Text PDFLeprosy reactions are acute exacerbations of the signs and symptoms of leprosy occurring during the natural course of the disease and during or after treatment. Left untreated or improperly managed, reactions can lead to severe nerve function impairment and subsequently to disabilities. In the present context of leprosy eradication efforts, leprosy reactions continue to pose a significant and enduring challenge.
View Article and Find Full Text PDFArticle Synopsis
- The microbiome, made up of various bacteria, is crucial for the immune system's development and overall bodily balance, and changes in these microbial communities can lead to inflammation and skin issues.
- Research indicates that dysbiosis in the skin and gut is linked to abnormal immune responses and skin barrier problems, playing a role in conditions like atopic dermatitis (AD).
- The study highlights the potential of focusing on the skin microbiome as a treatment for AD, suggesting that it could reduce the need for corticosteroids and encourages healthcare professionals to understand the microbiome's role in managing the condition.